• Glucose Intravenous Infusion 5% W/V 500ml
  • Glucose Intravenous Infusion 5% W/V 500ml
  • Glucose Intravenous Infusion 5% W/V 500ml
  • Glucose Intravenous Infusion 5% W/V 500ml
  • Glucose Intravenous Infusion 5% W/V 500ml
  • Glucose Intravenous Infusion 5% W/V 500ml

Glucose Intravenous Infusion 5% W/V 500ml

Application: Internal Medicine
Usage Mode: Liquid Injection
Suitable for: Adult
State: Liquid
Shape: Liquid Injection
Type: Biological Products
Samples:
US$ 0.01/Piece 1 Piece(Min.Order)
| Request Sample
Customization:
Gold Member Since 2019

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company

Basic Info.

Model NO.
5% W/V 500ml
Pharmaceutical Technology
Chemical Synthesis
Price
Low Price
Market
Africa
Transport Package
Carton
Specification
5% 500ml
Trademark
OEM
Origin
China
HS Code
3004909099
Production Capacity
100000000PCS

Product Description

Glucose injection, western medicine name. for nutritional medicine. Used to supplement energy and body fluids; used for various causes of insufficient food intake or massive body fluid loss (such as vomiting, diarrhea, etc.), total intravenous nutrition, starvation ketosis; hypoglycemia; hyperkalemia; hypertonic solution Used as tissue dehydrating agent; preparation of peritoneal dialysate; drug diluent; intravenous glucose tolerance test; for preparation of GIK (polarized fluid) solution.
Element
The main ingredient of this product is glucose.

traits
This product is colorless or almost colorless clear liquid; sweet taste.

Indications
This product is suitable for replenishing energy and body fluids; it is used for various reasons of insufficient food intake or massive body fluid loss (such as vomiting, diarrhea, etc.), total intravenous nutrition, starvation ketosis; hypoglycemia; hyperkalemia; hyperkalemia; The osmotic solution is used as a tissue dehydrating agent; preparation of peritoneal dialysis fluid; drug diluent; intravenous glucose tolerance test; for preparation of GIK (polarized fluid) solution.

Specification
(1) 10ml: 1g; (2) 10ml: 2g; (3) 10ml: 5g; (4) 20ml: 5g; (5) 20ml: 10g; (6) 50ml: 2.5g; (7) 50ml: 5g; (8) 100ml: 5g; (9) 100ml: 10g; (10) 100ml: 50g; (11) 200ml: 10g; (12) 250ml: 12.5g; (13) 250ml: 25g; (14) 250ml: 50g; (15) 250ml: 62.5g; (16) 250ml: 100g; (17) 250ml: 125g; (18) 300ml: 15g; (19) 500ml: 25g; (20) 500ml: 50g; (21) 500ml: 125g; (22) 1000ml: 50g; (23) 1000ml: 100g; (24) 1000ml: 250g.

Dosage
1. Supplementary heat energy: When the patient eats less or cannot eat for some reason, 25% glucose injection can generally be intravenously injected, and body fluids can be supplemented at the same time. The amount of glucose is calculated according to the required heat energy.

2. Intravenous nutrition therapy: Glucose is the most important energy supply substance for this therapy. In the non-protein heat energy, the ratio of glucose and fat supply heat is 2:1. The specific amount depends on the clinical heat needs. According to the needs of the rehydration volume, glucose can be formulated into different concentrations of 25%-50%, and  is added if necessary, and 1 unit of regular is added for every 5-10g of glucose. Due to the normal application of hypertonic glucose solution, which is more irritating to the vein and requires the infusion of fat emulsion, large intravenous drip is generally used.

3. Hypoglycemia: In severe cases, 20-40ml intravenous injection of 50% glucose injection can be given first.

4. Starvation ketosis: In severe cases, 5%-25% glucose injection should be administered intravenously, and 100g of glucose per day can basically control the condition.

5. Water loss: for isotonic water loss, 5% glucose injection is given intravenously.

6. Hyperkalemia: application of 10%-25% injection, plus 1 unit of regular  infusion per 2-4g of glucose, can reduce serum potassium concentration. However, this therapy only allows extracellular potassium ions to enter the cells, and the total potassium content in the body remains unchanged. If potassium excretion measures are not taken, there is still the possibility of recurrence of hyperkalemia.

7. Tissue dehydration: rapid intravenous injection of 20-50ml of hypertonic solution (generally 50% glucose injection). But the effect is short-lived. Clinical attention should be paid to preventing hyperglycemia, and it is rarely used at present. When used to adjust the osmotic pressure of peritoneal dialysate, 20ml of 50% glucose injection, that is, 10g of glucose, can increase the osmotic pressure of 1L of peritoneal dialysate by 55mOsm/kgH2O.

Adverse reactions
1. Phlebitis occurs when hypertonic glucose injection is instilled; such as large intravenous infusion, the incidence of phlebitis decreases.

2. The extravasation of high-concentration glucose injection can cause local swelling and pain.

3. Reactive hypoglycemia: It is easy to occur when combined use of is excessive, the original hypoglycemia tendency and the sudden stop of total intravenous nutrition therapy.

4. Hyperglycemia non-ketotic coma: more common in diabetes, stress state, the use of large amounts of glucocorticoids, uremic peritoneal dialysis patients given intraperitoneal hypertonic glucose solution and complete nutritional therapy.

5. Electrolyte imbalance: hypokalemia, hyponatremia and hypophosphatemia are prone to occur during long-term glucose supplementation alone.

6. Those with original cardiac insufficiency.

7. Hyperkalemia: Occasionally occur when patients with type 1 diabetes use high concentrations of glucose.

taboo
1. Those with uncontrolled diabetic ketoacidosis.

2, hyperglycemia non-ketotic hyperosmolar state.

storage
Keep tightly closed.

Glucose Intravenous Infusion 5% W/V 500mlGlucose Intravenous Infusion 5% W/V 500mlGlucose Intravenous Infusion 5% W/V 500ml
Glucose Intravenous Infusion 5% W/V 500ml

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2019

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company
Number of Employees
150
Year of Establishment
2004-01-16